LFST Valuation

LifeStance Health Group Inc

Add to Watchlist

Advanced Chart

5.550

+0.05(0.909%)1D

Overview
Forecast
Valuation
Earnings

LFST Relative Valuation

LFST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LFST is overvalued; if below, it's undervalued.

Historical Valuation

LifeStance Health Group Inc (LFST) is now in the Fair zone, suggesting that its current forward PS ratio of 1.38 is considered Fairly compared with the five-year average of -23.15. The fair price of LifeStance Health Group Inc (LFST) is between 3.57 to 18.32 according to relative valuation methord.

Relative Value

Fair Zone

3.57-18.32

Current Price：5.55

Fair

335.37

Trailing

Forward

15.14

EV/EBITDA

LifeStance Health Group Inc. (LFST) has a current EV/EBITDA of 15.14. The 5-year average EV/EBITDA is 47.19. The thresholds are as follows: Strongly Undervalued below -19.95, Undervalued between -19.95 and 13.62, Fairly Valued between 80.76 and 13.62, Overvalued between 80.76 and 114.33, and Strongly Overvalued above 114.33. The current Forward EV/EBITDA of 15.14 falls within the Historic Trend Line -Fairly Valued range.

108.73

EV/EBIT

LifeStance Health Group Inc. (LFST) has a current EV/EBIT of 108.73. The 5-year average EV/EBIT is -37.50. The thresholds are as follows: Strongly Undervalued below -255.38, Undervalued between -255.38 and -146.44, Fairly Valued between 71.44 and -146.44, Overvalued between 71.44 and 180.39, and Strongly Overvalued above 180.39. The current Forward EV/EBIT of 108.73 falls within the Overvalued range.

1.38

LifeStance Health Group Inc. (LFST) has a current PS of 1.38. The 5-year average PS is 3.06. The thresholds are as follows: Strongly Undervalued below -1.51, Undervalued between -1.51 and 0.77, Fairly Valued between 5.35 and 0.77, Overvalued between 5.35 and 7.64, and Strongly Overvalued above 7.64. The current Forward PS of 1.38 falls within the Historic Trend Line -Fairly Valued range.

15.79

P/OCF

LifeStance Health Group Inc. (LFST) has a current P/OCF of 15.79. The 5-year average P/OCF is 52.63. The thresholds are as follows: Strongly Undervalued below -32.40, Undervalued between -32.40 and 10.12, Fairly Valued between 95.14 and 10.12, Overvalued between 95.14 and 137.66, and Strongly Overvalued above 137.66. The current Forward P/OCF of 15.79 falls within the Historic Trend Line -Fairly Valued range.

18.93

P/FCF

LifeStance Health Group Inc. (LFST) has a current P/FCF of 18.93. The 5-year average P/FCF is -283.22. The thresholds are as follows: Strongly Undervalued below -3071.42, Undervalued between -3071.42 and -1677.32, Fairly Valued between 1110.88 and -1677.32, Overvalued between 1110.88 and 2504.98, and Strongly Overvalued above 2504.98. The current Forward P/FCF of 18.93 falls within the Historic Trend Line -Fairly Valued range.

LifeStance Health Group Inc (LFST) has a current Price-to-Book (P/B) ratio of 1.45. Compared to its 3-year average P/B ratio of 1.73 , the current P/B ratio is approximately -15.95% higher. Relative to its 5-year average P/B ratio of 2.34, the current P/B ratio is about -37.91% higher. LifeStance Health Group Inc (LFST) has a Forward Free Cash Flow (FCF) yield of approximately 5.77%. Compared to its 3-year average FCF yield of -0.30%, the current FCF yield is approximately -2036.47% lower. Relative to its 5-year average FCF yield of -0.91% , the current FCF yield is about -734.81% lower.

1.45

P/B

Median3y

1.73

Median5y

2.34

5.77

FCF Yield

Median3y

-0.30

Median5y

-0.91

Competitors Valuation Multiple

The average P/S ratio for LFST's competitors is 1.16, providing a benchmark for relative valuation. LifeStance Health Group Inc Corp (LFST) exhibits a P/S ratio of 1.38, which is 18.71% above the industry average. Given its robust revenue growth of 10.56%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

LFST.O

LifeStance Health Group Inc

Acadia Healthcare Company Inc

Aveanna Healthcare Holdings Inc

Pediatrix Medical Group Inc

Performance Decomposition

Market capitalization of LFST decreased by 12.04% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -80.14 to -130.33.

The secondary factor is the Revenue Growth, contributed 10.56%to the performance.

Overall, the performance of LFST in the past 1 year is driven by P/E Change. Which is more unsustainable.

10.56%

312.33M → 345.31M

Revenue Growth

-85.23%

-7.45 → -1.10

Margin Expansion

62.63%

-80.14 → -130.33

P/E Change

-12.04%